ADMA Biologics, Inc. beat EPS estimates 100% of the time across 1 reported quarters (1 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $0.16 | $0.16 | +0.0% | Beat |
| Q12026 FY2026 | — | $0.19 | — | Miss |
| Q42025 FY2025 | — | $0.20 | — | Miss |
Back to ADMA overview · ADMA holders · ADMA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.